{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:55:32Z","timestamp":1760608532460},"reference-count":52,"publisher":"Elsevier BV","issue":"2-3","license":[{"start":{"date-parts":[[2009,2,1]],"date-time":"2009-02-01T00:00:00Z","timestamp":1233446400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1016\/j.schres.2008.09.027","type":"journal-article","created":{"date-parts":[[2008,11,10]],"date-time":"2008-11-10T08:17:21Z","timestamp":1226305041000},"page":"150-157","source":"Crossref","is-referenced-by-count":34,"title":["Chronic risperidone treatment preferentially increases rat erythrocyte and prefrontal cortex omega-3 fatty acid composition: Evidence for augmented biosynthesis"],"prefix":"10.1016","volume":"107","author":[{"given":"Robert K.","family":"McNamara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica A.","family":"Able","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Jandacek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Therese","family":"Rider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Tso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.schres.2008.09.027_bib1","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib2","series-title":"International Conference of Schizophrenia Research","article-title":"Omega-3 fatty acids reduce the risk of early transition to psychosis in ultra-high risk individuals: a double-blind randomized, placebo-controlled treatment study","author":"Amminger","year":"2007"},{"issue":"6 Suppl","key":"10.1016\/j.schres.2008.09.027_bib3","doi-asserted-by":"crossref","first-page":"1467S","DOI":"10.1093\/ajcn\/83.6.1467S","article-title":"Distribution, interconversion, and dose response of omega-3 fatty acids in humans","volume":"83","author":"Arterburn","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.schres.2008.09.027_bib4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-3223(02)01443-9","article-title":"Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients","volume":"53","author":"Arvindakshan","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1079\/BJN20061801","article-title":"Polyunsaturated fatty acid concentrations in young men and women consuming their habitual diets","volume":"96","author":"Bakewell","year":"2006","journal-title":"Br. J. Nutr."},{"issue":"12","key":"10.1016\/j.schres.2008.09.027_bib6","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.4088\/JCP.v68n1206","article-title":"Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial","volume":"68","author":"Berger","year":"2007","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S0033291798008186","article-title":"The unhealthy lifestyle of people with schizophrenia","volume":"29","author":"Brown","year":"1999","journal-title":"Psychol. Med."},{"key":"10.1016\/j.schres.2008.09.027_bib8","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1080\/j.1440-1614.2006.01869.x","article-title":"Effect of omega-3 fatty acids on the lipid profile of patients taking clozapine","volume":"40","author":"Caniato","year":"2006","journal-title":"Aust. N. Z. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1017\/S0029665108005983","article-title":"Gender differences in the omega-3 fatty acid content of tissues","volume":"67","author":"Childs","year":"2008","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.schres.2008.09.027_bib10","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0022-2275(20)43209-2","article-title":"Dietary effects on brain fatty acid composition: the reversibility of omega-3 fatty acid deficiency and turnover of docosahexaenoic acid in the brain, erythrocytes, and plasma of rhesus monkeys","volume":"31","author":"Connor","year":"1990","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.schres.2008.09.027_bib11","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/00041433-200206000-00006","article-title":"Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues","volume":"13","author":"Contreras","year":"2002","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.schres.2008.09.027_bib12","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1176\/appi.ajp.159.9.1596","article-title":"Randomized, placebo-controlled study of ethyl-eicosapentaenoic acid as supplemental treatment in schizophrenia","volume":"159","author":"Emsley","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.plefa.2003.08.010","article-title":"Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment","volume":"69","author":"Evans","year":"2003","journal-title":"Prostaglandins Leukot. Essent. Fat. Acids"},{"key":"10.1016\/j.schres.2008.09.027_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00213-007-0833-9","article-title":"The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats","volume":"194","author":"Fell","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.schres.2008.09.027_bib15","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1176\/appi.ajp.158.12.2071","article-title":"A placebo-controlled trial of omega-3 fatty acid (ethyl eicosapentaenoic acid) supplementation for residual symptoms and cognitive impairment in schizophrenia","volume":"158","author":"Fenton","year":"2001","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib17","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1093\/ajcn\/80.5.1167","article-title":"Docosahexaenoic acid concentrations are higher in women than in men because of estrogenic effects","volume":"80","author":"Giltay","year":"2004","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.schres.2008.09.027_bib18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0022-2275(20)38310-3","article-title":"Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review","volume":"30","author":"Harris","year":"1989","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.schres.2008.09.027_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1001\/archpsyc.62.1.19","article-title":"Glucose metabolism in patients with schizophrenia treated with atypical antipsychotic agents: a frequently sampled intravenous glucose tolerance test and minimal model analysis","volume":"62","author":"Henderson","year":"2005","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1080\/10401230600614538","article-title":"Dietary intake profile of patients with schizophrenia","volume":"18","author":"Henderson","year":"2006","journal-title":"Ann. Clin. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0006-3223(02)01549-4","article-title":"Smoking, gender, and dietary influences on erythrocyte essential fatty acid composition among patients with schizophrenia or schizoaffective disorder","volume":"53","author":"Hibbeln","year":"2003","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib22","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/0006-3223(91)90235-E","article-title":"Fatty acid levels in the brains of schizophrenics and normal controls","volume":"30","author":"Horrobin","year":"1991","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib23","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1194\/jlr.M700315-JLR200","article-title":"Dietary omega-3 PUFA deprivation for 15\u00a0weeks upregulates elongase and desaturase expression in rat liver but not brain","volume":"48","author":"Igarashi","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.schres.2008.09.027_bib24","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1038\/sj.mp.4002000","article-title":"Metabolomic mapping of atypical antipsychotic effects in schizophrenia","volume":"12","author":"Kaddurah-Daouk","year":"2007","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib25","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.schres.2007.09.036","article-title":"Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients","volume":"98","author":"Kale","year":"2008","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2008.09.027_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0920-9964(01)00334-6","article-title":"Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics","volume":"58","author":"Khan","year":"2002","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2008.09.027_bib27","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/humu.9462","article-title":"Identification of novel mutations in PEX2, PEX6, PEX10, PEX12, and PEX13 in Zellweger spectrum patients","volume":"27","author":"Krause","year":"2006","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.schres.2008.09.027_bib28","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/01.ATV.14.3.471","article-title":"Plasma essential fatty acids, cigarette smoking, and dietary antioxidants in peripheral arterial disease. A population-based case\u2013control study","volume":"14","author":"Leng","year":"1994","journal-title":"Arterioscler. Thromb."},{"key":"10.1016\/j.schres.2008.09.027_bib29","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1042\/bj3500765","article-title":"Cloning of a human cDNA encoding a novel enzyme involved in the elongation of long-chain polyunsaturated fatty acids","volume":"350","author":"Leonard","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.schres.2008.09.027_bib30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.pnpbp.2005.11.034","article-title":"Sub-chronic antipsychotic drug treatment does not alter brain phospholipid fatty acid composition in rats","volume":"30","author":"Levant","year":"2006","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib31","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1086\/376549","article-title":"Genome scan meta-analysis of schizophrenia and bipolar disorder, part II: Schizophrenia","volume":"73","author":"Lewis","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.schres.2008.09.027_bib32","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-200746050-00001","article-title":"Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response","volume":"46","author":"Mauri","year":"2007","journal-title":"Clin. Pharmacokinet."},{"issue":"10","key":"10.1016\/j.schres.2008.09.027_bib33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1001\/archpsyc.59.10.921","article-title":"Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms","volume":"59","author":"McGorry","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.schres.2008.09.027_bib34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.schres.2006.11.027","article-title":"Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: gender differences and partial normalization with antipsychotic medications","volume":"91","author":"McNamara","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2008.09.027_bib53","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jpsychires.2007.05.009","article-title":"Omega-3 fatty acid deficiency augments amphetamine-induced behavioral sensitization in adult mice: prevention by chronic lithium treatment","volume":"42","author":"McNamara","year":"2008","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2008.09.027_bib35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.psychres.2007.08.021","article-title":"Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder","volume":"160","author":"McNamara","year":"2008","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.schres.2008.09.027_bib36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1021\/ac60235a044","article-title":"Rapid preparation of fatty acid esters from lipids for gas chromatographic analysis","volume":"38","author":"Metcalfe","year":"1966","journal-title":"Anal. Chem."},{"key":"10.1016\/j.schres.2008.09.027_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.schres.2004.01.014","article-title":"The effects of antipsychotic therapy on serum lipids: a comprehensive review","volume":"70","author":"Meyer","year":"2004","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2008.09.027_bib38","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0006-8993(01)02014-5","article-title":"Haloperidol downregulates phospholipase A(2) signaling in rat basal ganglia circuits","volume":"896","author":"Myers","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.schres.2008.09.027_bib39","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jada.2004.11.029","article-title":"n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review","volume":"105","author":"Nettleton","year":"2005","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.schres.2008.09.027_bib40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0022-3956(02)00048-1","article-title":"Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain","volume":"37","author":"Parikh","year":"2003","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.schres.2008.09.027_bib41","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/S0022-2275(20)31576-5","article-title":"Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans","volume":"42","author":"Pawlosky","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.schres.2008.09.027_bib42","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1530-0277.2001.tb02187.x","article-title":"Ethanol consumption alters electroretinograms and depletes neural tissues of docosahexaenoic acid in rhesus monkeys: nutritional consequences of a low omega-3 fatty acid diet","volume":"25","author":"Pawlosky","year":"2001","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"10.1016\/j.schres.2008.09.027_bib43","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0920-9964(00)00083-9","article-title":"Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia","volume":"49","author":"Peet","year":"2001","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.schres.2008.09.027_bib44","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1093\/oxfordjournals.schbul.a007140","article-title":"Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline","volume":"30","author":"Reddy","year":"2004","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.schres.2008.09.027_bib45","first-page":"1","article-title":"Evidence for an association between genetic variants of the fatty acid desaturase 1 fatty acid desaturase 2 (FADS1 FADS2) gene cluster and the fatty acid composition of erythrocyte membranes","volume":"15","author":"Rzehak","year":"2008","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.schres.2008.09.027_bib46","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/hmg\/ddl117","article-title":"Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids","volume":"15","author":"Schaeffer","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.schres.2008.09.027_bib47","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.schres.2005.03.002","article-title":"Dietary fatty acid and antioxidant intake in community-dwelling patients suffering from schizophrenia","volume":"76","author":"Strassnig","year":"2005","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2008.09.027_bib48","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF02193092","article-title":"Effect of neuroleptics on phospholipase A2 activity in the brain of rats","volume":"245","author":"Trzeciak","year":"1995","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.schres.2008.09.027_bib49","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1017\/S1461145708008468","article-title":"Increased expression of lipid biosynthesis genes in peripheral blood cells of olanzapine-treated patients","volume":"11","author":"Vik-Mo","year":"2008","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"4","key":"10.1016\/j.schres.2008.09.027_bib50","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-2275(20)31158-5","article-title":"Identification of a fatty acid delta6-desaturase deficiency in human skin fibroblasts","volume":"42","author":"Williard","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.schres.2008.09.027_bib51","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1079\/BJN20051539","article-title":"Distribution, depletion and recovery of docosahexaenoic acid are region-specific in rat brain","volume":"94","author":"Xiao","year":"2005","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.schres.2008.09.027_bib52","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0920-9964(99)00095-X","article-title":"Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients","volume":"42","author":"Yao","year":"2000","journal-title":"Schizophr. Res."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996408004519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996408004519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T23:25:14Z","timestamp":1684625114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996408004519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":52,"journal-issue":{"issue":"2-3","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["S0920996408004519"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2008.09.027","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}